NCT03689361View on ClinicalTrials.gov

Interest of the T2 * Sequence in MRI for the Diagnosis of Migraine Aura in the Acute Phase.

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 22, 2018

Primary Completion Date

October 11, 2020

Study Completion Date

December 11, 2020

Conditions
Migraine Aura
Interventions
COMBINATION_PRODUCT

MRI

Routine MRI with all the sequences performed for the management of acute neurological deficit in the Toulouse Neuro Vascular Unit (diffusion, FLAIR, T2 \*, vascular sequences (AngioRM and TOF) and perfusion).

DIAGNOSTIC_TEST

MRI control

MRI with all the sequences performed for the management of acute neurological deficit in the Toulouse Neuro Vascular Unit (diffusion, FLAIR, T2 \*, vascular sequences (AngioRM and TOF) and perfusion)

OTHER

telephone consultation

telephone consultation

Trial Locations (1)

31049

Hôpital Pierre Paul Riquet - CHU de Toulouse, Toulouse

All Listed Sponsors
lead

University Hospital, Toulouse

OTHER

NCT03689361 - Interest of the T2 * Sequence in MRI for the Diagnosis of Migraine Aura in the Acute Phase. | Biotech Hunter | Biotech Hunter